Tiziana Completes INFORM-MS Phase 2a Trial of Intranasal Foralumab
BOSTON, Mass. — September 21, 2026 Tiziana Life Sciences announced that the last patient has completed the last visit...
PET imaging
Advertisement
Telix Gains FDA Approval for Pixclara in Glioma Imaging
MELBOURNE, Australia and INDIANAPOLIS, Ind. — September 14, 2026 Telix Pharmaceuticals announced that the U.S. Food and Drug Administration...
Cortechs.ai Gains FDA Clearance for NeuroQuant PET
COVINGTON, Ky., August 18, 2026 Cortechs.ai announced that its NeuroQuant® PET platform has received FDA 510(k) clearance (K261916) for...
Curium to Merge with Lantheus in $8B Radiopharma Deal
Boston & Bedford, Massachusetts, August 3, 2026 Curium and Lantheus Holdings, Inc. have entered into a definitive merger agreement...
Tiziana Life Sciences Reports Positive Foralumab Data in Third MSA Patient
BOSTON, July 31, 2026 Tiziana Life Sciences announced new quantitative PET imaging results from the third patient with Multiple...
Advertisements
RefleXion Submits FDA 510(k) for Anchor Point Tracking
HAYWARD, Calif., June 30, 2026 RefleXion Medical has announced the submission of a 510(k) premarket notification to the U.S....
AC Immune Reports Positive Phase 1 ALS Imaging Data for ACI-19626
LAUSANNE, Switzerland, May 22, 2026 AC Immune announced new preliminary Phase 1 data showing that its investigational TDP-43 PET...
Bayer PET Tracer Shows Promise in Amyloidosis Study
BERLIN, Germany / WHIPPANY, N.J., May 7, 2026 Bayer announced positive topline results from the pivotal Phase III REVEAL...
Telix NDA Accepted for Pixclara Brain Cancer Imaging
Melbourne, Australia & Indianapolis, USA | April 10, 2026 Telix Pharmaceuticals has announced that the U.S. Food and Drug...
Clarity Co-PSMA Shows Superior Prostate Cancer Detection
SYDNEY, Australia, March 31, 2026 Clarity Pharmaceuticals has announced the publication of Phase II Co-PSMA clinical trial results in...
Advertisement
